FindTrial
Sign In

The incidence of Kidney Injury in neonates with heart diseases using Serum Creatinine and Serum Cystatin C

The incidence of Acute Kidney Injury in neonates with Congenital Heart Disease in a tertiary care hospital over a period of one year - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/054996
Enrollment
38
Registered
2023-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q219- Congenital malformation of cardiacseptum, unspecified

Interventions

None listed

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates with congenital heart disease

Exclusion criteria

Exclusion criteria: Neonates with renal anomalies Operated cases of congenital heart disease

Design outcomes

Primary

MeasureTime frame
To compare serum creatinine & serum cystatin c in detecting early Acute Kidney Injury in neonates with Congenital Heart DiseaseTimepoint: The study will be conducted over a span of one year—

Secondary

MeasureTime frame
To study the incidence of early acute kidney injury in neonates with congenital heart disease using serum creatinine & serum cystatin CTimepoint: The study will be conducted over a span of one year—

Countries

India

Contacts

Public ContactR Roshni

Division of Paediatric Nephrology, Department of Paediatrics, JNMC, Belgaum

patilmv1@gmail.com9483561674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026